Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: out_of_the_loop who wrote (961)	9/21/1999 8:34:00 PM
From: Mad2	Read Replies (1) \| Respond to of 5582

Howard do you really think these mundane details mean anything. QGLY claims "the only zinc loz proven to reduce the duration of the common cold in a double blind study". Thats a definitive statement, yet they give up sales to me too look alikes that may or may not be as effective.......Heres where advertizing (takes lots of money) comes in. P & G and other consumer marketers don't rely on technical details to sell. They make good products, market the brand and use their distribution strength to get it prominently on shelves. From a consumer advertizing perspective GUMM claims have no more impact than QGLY's I'd argue that Cold Ease loz's are more saleable, because the delivery is more convient and socially acceptable. How many people will carry loz's in their pockets and pop them on the train. A lot more than will carry a bottle, shove it in their nose....... Mad2